Interestingly, we found p-AKT and Bcl-2 downregulation in HCT-116 and MSTO-211 upon CF treatment, thus leading us to believe that CF can be used for the prevention of tumours and can possibly sensitize cancer cells to standard therapy. The gene discussed is BCL2; the disease is neoplasm.